The confirmed total of UK deaths from coronavirus in the UK has reached 33,614, it has been confirmed.
The Department for Health and Social Care has confirmed a further 428 deaths have been reported in the past 24 hours.
That’s the lowest increase on a non-bank holiday weekday since March 31.
On Friday May 8, a bank holiday, there were 346 deaths reproted.
The rise compares to a 494 death increase in the 24 hours prior and 627 deaths reported on Tuesday.
The daily update also said that there were 126,064 tests but only 71,644 people were tested as of 9am today.
Overall a total of 1,593,902 people have been tested of whom 233,151 tested positive.
Scotland has reported a further 34 hospital deaths due to coronavirus in the past 24 hours with 10 added to the death total in Wales.
Today it was reported that had been a 57% plunge in hospital attendances – largely attributed to a fear of catching the bug.
Downing Street said the “full impact” of the coronavirus pandemic would only be revealed by figures on excess deaths.
Experts have acknowledged there could be indirect deaths due to people being unable or unwilling to leave the home or from the NHS focusing on the coronavirus response at the expense of other services.
The Prime Minister’s official spokesman said: “It’s important to stress that the NHS has always been running services for those who needed urgent care and has shifted a lot of outpatient services to video and telephone calls.
“Trusts have been asked to start planning to bring back face-to-face, non-urgent services in a safe manner.
“That planning is under way but it’s right that that process is led by local clinicians based on how they think they can do that without putting patients and staff at unnecessary risks.”
Earlier today it was reported that the results of a human trial of a coronavirus vaccine could be available by the middle of June.
Professor Sir John Bell, regius professor of medicine at Oxford University, said “several hundred” people have been vaccinated and the challenge now is to be able to manufacture at scale once it is approved by the regulators.
At the end of April a team of researchers at Oxford started testing a Covid-19 vaccine in human volunteers.
Around 1,110 are expected to take part in the trial, half receiving the vaccine candidate and the other half (the control group) receiving a widely available meningitis vaccine.
Prof Bell told BBC Radio 4’s Today programme: “We also want to make sure that the rest of the world will be ready to make this vaccine at scale so that it gets to populations in developing countries, for example, where the need is very great.
“We really need a partner to do that and that partner has a big job in the UK because our manufacturing capacity in the UK for vaccines isn’t where it needs to be, and so we are going to work together with AstraZeneca to improve that considerably.”
He rejected the idea of challenge therapy – that would deliberately infect healthy volunteers with coronavirus – and said there should be results on the vaccine trial by using normal exposure to the virus, if you keep your head down.